It starts getting crazy when you consider that anthracyclines are currently third line (or later) BC treatment options in the US. This revenue forecast is based on the current anthracycline market share. If Zan does indeed increase the efficacy of anthracyclines, while making them safer, you'd have to expect their market share to increase.
US$5B for one indication. Anthracyclines are approved for use in 20 other indications - not including any off-label use. Might take a couple of weeks for this to sink in - but it should.
- Forums
- ASX - By Stock
- Ann: Race releases cardioprotection market potential data
It starts getting crazy when you consider that anthracyclines...
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.040(2.84%) |
Mkt cap ! $239.5M |
Open | High | Low | Value | Volume |
$1.43 | $1.48 | $1.43 | $131.3K | 90.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 1100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4700 | 1.450 |
1 | 4300 | 1.445 |
1 | 20000 | 1.440 |
1 | 250 | 1.430 |
1 | 4991 | 1.425 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 1100 | 1 |
1.470 | 1500 | 1 |
1.475 | 1456 | 1 |
1.485 | 9219 | 1 |
1.490 | 6375 | 1 |
Last trade - 12.04pm 13/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.45 |
  |
Change
0.040 ( 4.38 %) |
|||
Open | High | Low | Volume | ||
$1.45 | $1.47 | $1.44 | 3496 | ||
Last updated 12.28pm 13/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online